Amgen Inc. (NASDAQ: AMGN) Q1 2021 earnings call dated Apr. 27, 2021 Corporate Participants: Arvind Sood -- Vice President, Investor Relations Robert A. Bradway -- Chairman
Amgen Inc. (AMGN) Q1 2021 Earnings Call Transcript
Amgen Inc. (NASDAQ: AMGN) Q1 2021 earnings call dated Apr. 27, 2021 Corporate Participants: Arvind Sood -- Vice President, Investor Relations Robert A. Bradway -- Chairman
Eli Lilly and Company (NYSE: LLY) Q1 2021 earnings call dated Apr. 27, 2021 Corporate Participants: Kevin Hern -- Vice President, Investor Relations David A.
Trxade Group Inc. (NASDAQ: MEDS) Q1 2021 earnings call dated Apr. 26, 2021 Corporate Participants: Howard Doss -- Chief Financial Officer Suren Ajjarapu -- Chief Executive
Trxade (NASDAQ: MEDS) on Monday posted a 39% increase in first-quarter revenues to $3.1 million due to higher sales in the Integra
Koninklijke Philips N.V. (NYSE: PHG) Q1 2021 earnings call dated Apr. 26, 2021 Corporate Participants: Leandro Mazzoni -- Head of Investor Relations Frans van
IQVIA Holdings Inc. (NYSE: IQV) Q1 2021 earnings call dated Apr. 22, 2021. Corporate Participants: Andrew Markwick -- Senior Vice President, Investor
Biogen Inc. (NASDAQ: BIIB) Q1 2021 earnings call dated Apr. 22, 2021 Corporate Participants: Mike Hencke -- Director of Investor Relations Michel Vounatsos -- Chief Executive
Quest Diagnostics Inc (NYSE: DGX) Q1 2021 earnings call ended Apr. 22, 2021 Corporate Participants: Shawn Bevec -- Vice President of Investor Relations Stephen
Biogen Inc. (NASDAQ: BIIB) reported first quarter 2021 earnings results today. Total revenues decreased 24% year-over-year to $2.6 billion. On a constant
Shares of Intuitive Surgical Inc. (NASDAQ: ISRG) were up over 10% on Wednesday. The stock has gained 74% over the past 12
Johnson & Johnson (NYSE: JNJ) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Christopher DelOrefice — Vice President of Investor Relations Joseph J. Wolk — Executive Vice
Anthem, Inc. (NYSE: ANTM) Q1 2021 earnings call dated Apr. 21, 2021 Corporate Participants: Stephen Tanal -- Vice President of Investor Relations Gail K.
Intuitive Surgical Inc. (NASDAQ: ISRG) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Philip Kim -- Head of Investor Relations Gary S.
Edwards Lifesciences Corp. (NYSE: EW) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Mark Wilterding -- Vice President, Investor Relations Michael A.
Intuitive Surgical, Inc. (NASDAQ: ISRG) reported first quarter 2021 earnings results today. Revenues increased 18% year-over-year to $1.29 billion, driven by growth
Johnson & Johnson (NYSE: JNJ) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Christopher DelOrefice -- Vice President of Investor Relations Joseph
Abbott Laboratories (NYSE: ABT) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Scott Michael Leinenweber -- Vice President of Investor Relations, Licensing
Abbott Laboratories (NYSE: ABT) reported first quarter 2021 earnings results today. Sales increased 35.3% year-over-year to $10.5 billion. On an organic basis,
Johnson & Johnson (NYSE: JNJ) reported first-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue
Mitesco Inc (OTCQB: MITI) CEO Lawrence Diamond, a man with over 25 years of experience in the healthcare space, strongly feels that
UnitedHealth Group Inc. (NYSE: UNH) Q1 2021 earnings call dated Apr. 15, 2021 Corporate Participants: Andrew Witty -- Chief Executive Officer Dirk McMahon -- President and